Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD).
Wigal TL, Newcorn JH, Handal N, Wigal SB, Mulligan I, Schmith V, Konofal E. Wigal TL, et al. Among authors: mulligan i. CNS Drugs. 2018 Mar;32(3):289-301. doi: 10.1007/s40263-018-0503-y. CNS Drugs. 2018. PMID: 29557078 Free PMC article. Clinical Trial.
31 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page